JCR Pharmaceuticals Co Ltd 2023 Sustainability Report
The report presents JCR's sustainability approach around rare diseases, environment, society and corporate governance, with access to medicines and support for underserved patients as central themes. It describes sustainability committees and Board reporting, alongside a materiality-identification process. FY2022 climate disclosure reports 3,315 tons of Scope 1, 7,670 tons of location-standard Scope 2 and 79,466 tons of Scope 3 emissions calculated according to the GHG Protocol. It also describes water-use management, renewable energy at Kobe Science Park Center, waste recycling and human-capital initiatives including JCR Academy.
Company: JCR Pharmaceuticals Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Sustainability Report
Pages: 48
Back to company
JCR Pharmaceuticals Co Ltd
Sustainability Report
The report presents JCR's sustainability approach around rare diseases, environment, society and corporate governance, with access to medicines and support for underserved patients as central themes. It describes sustainability committees and Board reporting, alongside a materiality-identification process. FY2022 climate disclosure reports 3,315 tons of Scope 1, 7,670 tons of location-standard Scope 2 and 79,466 tons of Scope 3 emissions calculated according to the GHG Protocol. It also describes water-use management, renewable energy at Kobe Science Park Center, waste recycling and human-capital initiatives including JCR Academy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Published
Nov 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Women in Management
Employees